ATE251912T1 - Verwendung des erythropoietins zur behandlung von rheumatoider arthritis - Google Patents
Verwendung des erythropoietins zur behandlung von rheumatoider arthritisInfo
- Publication number
- ATE251912T1 ATE251912T1 AT95936127T AT95936127T ATE251912T1 AT E251912 T1 ATE251912 T1 AT E251912T1 AT 95936127 T AT95936127 T AT 95936127T AT 95936127 T AT95936127 T AT 95936127T AT E251912 T1 ATE251912 T1 AT E251912T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- rheumatoid arthritis
- erythropoietin
- epo
- seen
- Prior art date
Links
- 102000003951 Erythropoietin Human genes 0.000 title abstract 4
- 108090000394 Erythropoietin Proteins 0.000 title abstract 4
- 229940105423 erythropoietin Drugs 0.000 title abstract 3
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title abstract 3
- 206010039073 rheumatoid arthritis Diseases 0.000 title abstract 3
- 206010023232 Joint swelling Diseases 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 230000006020 chronic inflammation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94203205 | 1994-11-03 | ||
| PCT/NL1995/000370 WO1996014081A1 (en) | 1994-11-03 | 1995-10-26 | Use of erythropoietin in the treatment of rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE251912T1 true ATE251912T1 (de) | 2003-11-15 |
Family
ID=8217342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95936127T ATE251912T1 (de) | 1994-11-03 | 1995-10-26 | Verwendung des erythropoietins zur behandlung von rheumatoider arthritis |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7344717B1 (de) |
| EP (1) | EP0784480B1 (de) |
| AT (1) | ATE251912T1 (de) |
| AU (1) | AU3817495A (de) |
| DE (1) | DE69531952T2 (de) |
| ES (1) | ES2206521T3 (de) |
| IL (1) | IL115826A (de) |
| WO (1) | WO1996014081A1 (de) |
| ZA (1) | ZA959325B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952226A (en) * | 1996-11-05 | 1999-09-14 | Modex Therapeutiques | Hypoxia responsive EPO producing cells |
| DE19734293A1 (de) * | 1997-08-08 | 1999-02-11 | Boehringer Mannheim Gmbh | Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen |
| NZ522851A (en) * | 2000-05-02 | 2004-11-26 | Action Pharma Aps | Treatment of inflammatory diseases associated with neutrophil or eosinophil granulocyt inflitration with EPO optionally with alpha-MSH |
| RU2197986C2 (ru) * | 2001-03-23 | 2003-02-10 | Волчек Игорь Анатольевич | Иммуномодулирующее средство неинъекционного применения |
| DE10234192B4 (de) | 2002-07-26 | 2009-11-26 | Epoplus Gmbh Co.Kg | Verwendung von Erythropoetin |
| RU2257216C2 (ru) * | 2003-06-11 | 2005-07-27 | Ханис Александр Юрьевич | Иммуномодулирующее средство риботаб |
| US9610444B2 (en) | 2013-03-15 | 2017-04-04 | Pacesetter, Inc. | Erythropoeitin production by electrical stimulation |
| WO2022243996A1 (en) * | 2021-05-18 | 2022-11-24 | Attias Eyal | Use of erythropoietin (epo) or erythropoiesis-stimulating agent (esa) to treat osteomyelitis, bone infection, and bone inflammation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4732889A (en) | 1985-02-06 | 1988-03-22 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis |
| US5013718A (en) * | 1986-11-21 | 1991-05-07 | Amgen, Inc. | Method for treating iron overload using EPO |
-
1995
- 1995-10-26 ES ES95936127T patent/ES2206521T3/es not_active Expired - Lifetime
- 1995-10-26 US US08/817,704 patent/US7344717B1/en not_active Expired - Fee Related
- 1995-10-26 AT AT95936127T patent/ATE251912T1/de active
- 1995-10-26 EP EP95936127A patent/EP0784480B1/de not_active Expired - Lifetime
- 1995-10-26 DE DE69531952T patent/DE69531952T2/de not_active Expired - Lifetime
- 1995-10-26 AU AU38174/95A patent/AU3817495A/en not_active Abandoned
- 1995-10-26 WO PCT/NL1995/000370 patent/WO1996014081A1/en not_active Ceased
- 1995-10-31 IL IL11582695A patent/IL115826A/xx not_active IP Right Cessation
- 1995-11-03 ZA ZA959325A patent/ZA959325B/xx unknown
-
2007
- 2007-06-11 US US11/811,665 patent/US9155782B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69531952T2 (de) | 2004-07-29 |
| US9155782B2 (en) | 2015-10-13 |
| EP0784480A1 (de) | 1997-07-23 |
| US7344717B1 (en) | 2008-03-18 |
| IL115826A0 (en) | 1996-01-19 |
| WO1996014081A1 (en) | 1996-05-17 |
| DE69531952D1 (de) | 2003-11-20 |
| AU3817495A (en) | 1996-05-31 |
| IL115826A (en) | 2000-07-26 |
| US20070249525A1 (en) | 2007-10-25 |
| ES2206521T3 (es) | 2004-05-16 |
| ZA959325B (en) | 1996-05-29 |
| EP0784480B1 (de) | 2003-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
| AU1049788A (en) | Methods and peptides for the treatment of non-ige-mediated diseases | |
| DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| FI962557A0 (fi) | PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa | |
| ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| NO972391L (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
| ATE239474T1 (de) | Verwendung von levobupivacain | |
| DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| DE69631656D1 (de) | Debromhymenialdisin und verwandte verbindungen zur behandlung von osteoarthritis | |
| DE69531952D1 (de) | Verwendung des erythropoietins zur behandlung von rheumatoider arthritis | |
| ES2072490T3 (es) | Procedimiento para la pasteurizacion de la proteina tisular pp4. | |
| DE68921229D1 (de) | Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein. | |
| DE69805305D1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| NO972449L (no) | Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav | |
| ATE151774T1 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen | |
| ATE227557T1 (de) | Verwendung von zahnpflegemitteln enthaltend bovines kolostrum | |
| DE69619051D1 (de) | Behandlung von Füllstoffen mit Oxasilacycloalkanen | |
| ATE218856T1 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
| EP0830057A4 (de) | Verfahren zur inaktivierung von viralen und bakteriellen blutverunreinigungen | |
| DE69736180D1 (de) | Behandlung von manischen erkrankungen | |
| FR2710539B1 (fr) | Ensemble d'aiguille chirurgicale. | |
| DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
| DE69721484D1 (de) | Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten | |
| DE59609977D1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
| DE69734890D1 (de) | Rdgb-proteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0784480 Country of ref document: EP |